Skip to main content
Top
Published in: Clinical Rheumatology 3/2017

01-03-2017 | Original Article

Comorbidity of gout and rheumatoid arthritis in a large population database

Authors: Rona Merdler-Rabinowicz, Shmuel Tiosano, Doron Comaneshter, Arnon D. Cohen, Howard Amital

Published in: Clinical Rheumatology | Issue 3/2017

Login to get access

Abstract

Coexistence of rheumatoid arthritis and gout is considered to be unusual. The current study was designed as a population-based cross-sectional study, utilizing the medical database of Clalit Health Services, the largest healthcare provider organization in Israel. Data of adult patients who were previously diagnosed with rheumatoid arthritis was retrieved. For each patient, five age- and sex-matched control patients were randomly selected. Different parameters including BMI, socioeconomic status, and existence of gout as well as smoking and hypertension were examined for both groups. The study included 11,540 patients with rheumatoid arthritis and 56,763 controls. The proportion of gout in the study group was high compared to controls (1.61 vs. 0.92%, P < 0.001). In a multivariate analysis, rheumatoid arthritis was associated with gout (OR = 1.72, 95% CI 1.45–2.05, P = 0.00). The proportion of gout in rheumatoid arthritis patients is not lower than in the general population.
Literature
1.
go back to reference Houri LE, Watad A, Whitby A, Tiosano S, Comaneshter D, Cohen AD et al (2016) Coexistence of ischemic heart disease and rheumatoid arthritis patients—a case control study. Autoimmun Rev 15(4):393–396CrossRef Houri LE, Watad A, Whitby A, Tiosano S, Comaneshter D, Cohen AD et al (2016) Coexistence of ischemic heart disease and rheumatoid arthritis patients—a case control study. Autoimmun Rev 15(4):393–396CrossRef
2.
go back to reference Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11(3):229CrossRefPubMedPubMedCentral Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11(3):229CrossRefPubMedPubMedCentral
3.
4.
go back to reference Liu R, Han C, Wu D, Xia X, Gu J, Guan H et al (2015) Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015:762820PubMedPubMedCentral Liu R, Han C, Wu D, Xia X, Gu J, Guan H et al (2015) Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015:762820PubMedPubMedCentral
5.
go back to reference Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G (2013) Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology (Oxford) 52(6):1126–1131CrossRef Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G (2013) Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology (Oxford) 52(6):1126–1131CrossRef
6.
go back to reference Kuo CF, Tsai WP, Liou LB (2008) Rare copresent rheumatoid arthritis and gout: comparison with pure rheumatoid arthritis and a literature review. Clin Rheumatol 27(2):231–235CrossRefPubMed Kuo CF, Tsai WP, Liou LB (2008) Rare copresent rheumatoid arthritis and gout: comparison with pure rheumatoid arthritis and a literature review. Clin Rheumatol 27(2):231–235CrossRefPubMed
7.
go back to reference Jebakumar AJ, Udayakumar PD, Crowson CS, Matteson EL (2013) Occurrence of gout in rheumatoid arthritis: it does happen! A population-based study. Int J Clin Rheumtol 8(4):433–437CrossRefPubMedPubMedCentral Jebakumar AJ, Udayakumar PD, Crowson CS, Matteson EL (2013) Occurrence of gout in rheumatoid arthritis: it does happen! A population-based study. Int J Clin Rheumtol 8(4):433–437CrossRefPubMedPubMedCentral
8.
go back to reference Bieber V, Cohen AD, Freud T, Agmon-Levin N, Gertel S, Amital H (2013) Autoimmune smoke and fire—coexisting rheumatoid arthritis and chronic obstructive pulmonary disease: a cross-sectional analysis. Immunol Res 56(2–3):261–266CrossRefPubMed Bieber V, Cohen AD, Freud T, Agmon-Levin N, Gertel S, Amital H (2013) Autoimmune smoke and fire—coexisting rheumatoid arthritis and chronic obstructive pulmonary disease: a cross-sectional analysis. Immunol Res 56(2–3):261–266CrossRefPubMed
9.
go back to reference Dahan S, Shor DB, Comaneshter D, Tekes-Manova D, Shovman O, Amital H et al (2016) All disease begins in the gut: celiac disease co-existence with SLE. Autoimmun Rev 15(8):848–853CrossRefPubMed Dahan S, Shor DB, Comaneshter D, Tekes-Manova D, Shovman O, Amital H et al (2016) All disease begins in the gut: celiac disease co-existence with SLE. Autoimmun Rev 15(8):848–853CrossRefPubMed
10.
go back to reference Guy A, Tiosano S, Comaneshter D, Tekes-Manova D, Shovman O, Cohen AD et al. (2016) Aortic aneurysm association with lupus Guy A, Tiosano S, Comaneshter D, Tekes-Manova D, Shovman O, Cohen AD et al. (2016) Aortic aneurysm association with lupus
11.
go back to reference Watad A, Cohen AD, Comaneshter D, Tekes-Manova D, Amital H (2016) Hyperthyroidism association with SLE, lessons from real-life data—a case-control study. Autoimmunity 49(1):17–20CrossRefPubMed Watad A, Cohen AD, Comaneshter D, Tekes-Manova D, Amital H (2016) Hyperthyroidism association with SLE, lessons from real-life data—a case-control study. Autoimmunity 49(1):17–20CrossRefPubMed
12.
go back to reference MacFarlane LA, Kim SC (2014) Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin N Am 40(4):581–604CrossRef MacFarlane LA, Kim SC (2014) Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin N Am 40(4):581–604CrossRef
13.
go back to reference Schlesinger N (2014) Treatment of acute gout. Rheum Dis Clin N Am 40(2):329–341CrossRef Schlesinger N (2014) Treatment of acute gout. Rheum Dis Clin N Am 40(2):329–341CrossRef
14.
go back to reference Yardim-Akaydin S, Sepici A, Ozkan Y, Torun M, Simsek B, Sepici V (2004) Oxidation of uric acid in rheumatoid arthritis: is allantoin a marker of oxidative stress? Free Radic Res 38(6):623–628CrossRefPubMed Yardim-Akaydin S, Sepici A, Ozkan Y, Torun M, Simsek B, Sepici V (2004) Oxidation of uric acid in rheumatoid arthritis: is allantoin a marker of oxidative stress? Free Radic Res 38(6):623–628CrossRefPubMed
15.
go back to reference Shovman O, Tiosano S, Comaneshter D, Cohen AD, Amital H, Sherf M (2016) Aortic aneurysm associated with rheumatoid arthritis: a population-based cross-sectional study. Clin Rheumatol Shovman O, Tiosano S, Comaneshter D, Cohen AD, Amital H, Sherf M (2016) Aortic aneurysm associated with rheumatoid arthritis: a population-based cross-sectional study. Clin Rheumatol
Metadata
Title
Comorbidity of gout and rheumatoid arthritis in a large population database
Authors
Rona Merdler-Rabinowicz
Shmuel Tiosano
Doron Comaneshter
Arnon D. Cohen
Howard Amital
Publication date
01-03-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3477-5

Other articles of this Issue 3/2017

Clinical Rheumatology 3/2017 Go to the issue